Skip to main content

Surgical Complication

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Functional AssessmentN/A1 trial
Active Trials
NCT01943773Completed16Est. Dec 2014
Verona Pharma
Verona PharmaUK - London
1 program
Immediate urinary catheter removalN/A1 trial
Active Trials
NCT05249192Completed216Est. Nov 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Verona PharmaImmediate urinary catheter removal
Colorado TherapeuticsFunctional Assessment

Clinical Trials (2)

Total enrollment: 232 patients across 2 trials

NCT05249192Verona PharmaImmediate urinary catheter removal

Immediate Versus Early (24-hours) Urinary Catheter Removal After Elective Minimally Invasive Colonic Resection

Start: Feb 2022Est. completion: Nov 2024216 patients
N/ACompleted

Functional Prehabilitation and Major Elective Surgery

Start: Mar 2013Est. completion: Dec 201416 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.